Compare KALV & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALV | MLKN |
|---|---|---|
| Founded | N/A | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2014 | 1994 |
| Metric | KALV | MLKN |
|---|---|---|
| Price | $26.76 | $14.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.60 | N/A |
| AVG Volume (30 Days) | ★ 5.0M | 624.6K |
| Earning Date | 07-09-2026 | 03-25-2026 |
| Dividend Yield | N/A | ★ 4.71% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | $50,000,000.00 | ★ $3,669,900,000.00 |
| Revenue This Year | $185.42 | $5.94 |
| Revenue Next Year | $59.23 | $3.78 |
| P/E Ratio | ★ N/A | $14.80 |
| Revenue Growth | ★ 495.66 | 1.14 |
| 52 Week Low | $9.83 | $13.77 |
| 52 Week High | $26.85 | $23.18 |
| Indicator | KALV | MLKN |
|---|---|---|
| Relative Strength Index (RSI) | 74.87 | 37.13 |
| Support Level | $14.45 | $13.81 |
| Resistance Level | N/A | $16.34 |
| Average True Range (ATR) | 0.07 | 0.59 |
| MACD | -0.06 | -0.14 |
| Stochastic Oscillator | 54.55 | 9.63 |
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.